-- Jeffrey W. Albers, directeur, a vendu, le 21 janvier 2025, 15 161 actions de Blueprint Medicines pour un montant de 1 660 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback